Author

Simon Dubovik

Belarusian State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Research Focus:software / tool· 1

Frequent Co-Authors

Alexandr A. MigasiD· 2 shared Dmitri DormeshkiniD· 2 shared Alexander MeleshkoiD· 1 shared Anton KavaleuskiiD· 1 shared Michail A. ShapiraiD· 1 shared Mikalai Katsin· 1 shared Sergei Semyonov· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Alexandr A. MigasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Modular Cell Line for Scalable and Rapid In Vitro Evaluation of Chimeric Antigen Receptors

Simon Dubovik, Dmitri Dormeshkin, Alexandr A. Migas

The paper introduces a modular cell line system for rapid in vitro evaluation of CAR-T cells by anchoring ALFA-tagged proteins on the cell surface using anti-ALFA-tag antibodies.

Protein Expression and Purification · May 13, 2025Peer-reviewedCell Biology

Development of an Escape-resistant SARS CoV-2 Neutralizing Synthetic Nanobody

Dmitri Dormeshkin, Michail A. Shapira, Simon Dubovik, Anton Kavaleuski, Mikalai Katsin, Alexandr A. Migas, Alexander Meleshko, Sergei Semyonov

The paper develops synthetic nanobodies that neutralize SARS-CoV-2 variants with high affinity and low susceptibility to mutations.

Frontiers in Immunology · Sep 16, 2022Peer-reviewedSynthetic Biology